Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications
Retraction notice to "Understanding microbiota-driven oncogenesis: The role of metabolites in tumorigenesis" [iScience 28 (2025) 113945].
Journal: iScience
Published: July 28, 2026
Development of Albumin Nanocarriers for Enhanced Curcumin Delivery and In Vitro Anticancer Activity in Colon Cancer Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 20, 2026
Prescribing Errors and Pharmacist Interventions in Paediatric Primary Health Care in Saudi Arabia: A Mixed-Methods Study.
Journal: Healthcare (Basel, Switzerland)
Published: January 27, 2026
Understanding microbiota-driven oncogenesis: The role of metabolites in tumorigenesis.
Journal: iScience
Published: December 03, 2025
The advancements in targeted therapeutic strategies for breast cancer via intervention of natural molecules: An insight into cellular and molecular mechanisms.
Journal: Pathology, research and practice
Published: October 28, 2025
The maternal and infant gut microbiome: implications for pregnancy outcomes, immune development, and health in the first 1000 days.
Journal: Journal of translational medicine
Published: October 18, 2025
Phytochemical-Based Nanotherapeutics for Skin Cancer: A Critical Appraisal of Current Strategies, Challenges, and Future Perspectives.
Journal: Chemistry & biodiversity
Published: August 08, 2025
A Computational Approach for Graphene Doped with N,P,B Structures as Possible Electrode Materials for Potassium Ion Batteries (PIBs): A DFT Investigation.
Journal: Micromachines
Published: April 09, 2025
Alantolactone protects against doxorubicin-induced nephrotoxicity by modulating Nrf2/HO-1, NF-κB, and Bax/Bcl-2 activity: molecular and in silico insights.
Journal: Molecular biology reports
Published: March 20, 2025
Major risk factors underlying the development of metabolic syndrome in vitamin D-deficient rats.
Journal: Frontiers in pharmacology
Published: February 08, 2025
LINE-1 retrotransposon activation drives age-associated inflammation via cytoplasmic cDNA-STING/type I interferon signalling: therapeutic potential of reverse transcriptase inhibition.
Journal: Contemporary oncology (Poznan, Poland)
Published: January 27, 2025
Last Updated: 09/26/2026